Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics
Semaglutide and Tirzepatide cannot be prescribed to anyone with the following conditions and should not be purchased: BMI under 26, Gastroparesis (paralysis of your intestines), Triglycerides over 600 at any point, Pancreatic cancer, Pancreatitis, Type 1 diabetes, Hypoglycemia (low blood sugar), Insulin-dependent diabetes, Thyroid cancer, Family history of thyroid cancer, Personal or family history of Multiple Endocrine Neoplasia (MEN-2) syndrome, Anorexia or bulimia, Current symptomatic gallstones, Drug or alcohol abuse, Recent bariatric surgery, Diabetic retinopathy, current pregnancy or breastfeeding, plans to become pregnant, or history of allergic reaction to Semaglutide or Tirzepatide
The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimers dementia
specifically, what it was intended to support, and where in the document that could be located [7]